{
    "clinical_study": {
        "@rank": "104052", 
        "arm_group": [
            {
                "arm_group_label": "Nitrate supplement with caffeine", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance"
        }, 
        "brief_title": "Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Regular commuter cyclist or spin class participant\n\n          -  Male (VO2max < 50) or Female (VO2max < 45)\n\n          -  Healthy\n\n          -  Blood pressure below 140/90\n\n          -  Non-smoker\n\n        Exclusion Criteria:\n\n          -  Does not cycle 2-3 times/week\n\n          -  Regular consumption of performance-enhancing substances\n\n          -  Type I or Type II diabetes\n\n          -  Renal, hepatic or cardiac disease\n\n          -  Current infectious disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "49 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01710761", 
            "org_study_id": "2012-05-0033"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "description": "Same form factor and flavor as test lozenge but contains no active ingredients", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Nitrate supplement with caffeine", 
                "description": "Lozenge consisting of beetroot and 75 mg caffeine", 
                "intervention_name": "Nitrate supplement with caffeine", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Caffeine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "nitric oxide", 
            "cycling performance", 
            "lactate", 
            "VO2"
        ], 
        "lastchanged_date": "January 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Austin", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "78712"
                }, 
                "name": "The University of Texas at Austin"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance", 
        "overall_official": {
            "affiliation": "The University of Texas at Austin", 
            "last_name": "Lynne Kammer-Kerwick, MSE, MA", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Participants will cycle 20 min at increasing intensity: 8 min at 55% VO2max, 6 min at 65% VO2max, 6 min at 75% VO2max.  The 20 km time trial consists of rolling hills.", 
            "measure": "Improved Time Trial Performance", 
            "safety_issue": "No", 
            "time_frame": "After 20 min steady-state cycling"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01710761"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Expired gases will be collected and compared to expected VO2.  Blood will be collected prior to treatment, prior to exercise and during each cycling intensity to analyze lactate accumulation.", 
            "measure": "Improved work efficiency", 
            "safety_issue": "No", 
            "time_frame": "During 20 min steady-state cycling"
        }, 
        "source": "University of Texas at Austin", 
        "sponsors": {
            "collaborator": {
                "agency": "Neogenis Laboratories", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Texas at Austin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}